Myelodysplasia News and Research

RSS
Data from pacritinib Phase 3 PERSIST-1 trial in patients with myelofibrosis to be highlighted at ASCO

Data from pacritinib Phase 3 PERSIST-1 trial in patients with myelofibrosis to be highlighted at ASCO

Actimab-A extends overall survival, reduces bone marrow blasts in older AML patients

Actimab-A extends overall survival, reduces bone marrow blasts in older AML patients

New standard of care for pediatric AML patients who receive umbilical cord transplants

New standard of care for pediatric AML patients who receive umbilical cord transplants

Researchers discover pre-leukemic stem cell that triggers relapse in patients with AML

Researchers discover pre-leukemic stem cell that triggers relapse in patients with AML

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

Zebrafish provides insight into human melanoma

Zebrafish provides insight into human melanoma

Researchers identify frequent SF3B1 gene mutation in myelodysplasia

Researchers identify frequent SF3B1 gene mutation in myelodysplasia

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Jefferson's two-step bone marrow transplant procedure holds promise for cancer patients

Jefferson's two-step bone marrow transplant procedure holds promise for cancer patients

Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting

Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting

Cellerant commences CLT-008 Phase I/II trial in patients with leukemia

Cellerant commences CLT-008 Phase I/II trial in patients with leukemia

Oncologists to discuss treatment of blood cancer in elderly

Oncologists to discuss treatment of blood cancer in elderly

Quebec reimburses VIDAZA for treatment of blood cancer

Quebec reimburses VIDAZA for treatment of blood cancer

SAGE launches two new journals in Drug Safety, Hematology

SAGE launches two new journals in Drug Safety, Hematology

NCF announces formal disease model for Chronic Fatigue Syndrome

NCF announces formal disease model for Chronic Fatigue Syndrome

Sanofi-aventis receives FDA approval for new Taxotere Injection Concentrate formulation

Sanofi-aventis receives FDA approval for new Taxotere Injection Concentrate formulation

New research project to discover origin of myelodysplasia

New research project to discover origin of myelodysplasia

Research team confirms gene mutation associated with serious forms of leukaemia

Research team confirms gene mutation associated with serious forms of leukaemia

Spectrum Pharmaceuticals to present clinical data on belinostat at ASCO 2010

Spectrum Pharmaceuticals to present clinical data on belinostat at ASCO 2010

Vion Pharmaceuticals files for bankruptcy

Vion Pharmaceuticals files for bankruptcy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.